FindTrial
Sign In

staining method

OTHER2 trials

Sponsors

Fred Hutchinson Cancer Center, Mayo Clinic

Conditions

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)B-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaChildhood Chronic Myelogenous Leukemia

Phase 1

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
CompletedNCT00052520
Fred Hutchinson Cancer CenterAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) +20
Start: 2002-09-30End: 2013-06-30Updated: 2017-03-29

Phase 2

Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
CompletedNCT01328535
Mayo ClinicRecurrent Melanoma, Stage IV Melanoma
Start: 2011-01-31End: 2018-07-11Updated: 2020-10-22